J.L. Bainbridge & Co’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
Other funds holding ABBV
J.L. Bainbridge & Co's ABBV Position: Q2 2026 in Review
J.L. Bainbridge & Co reduced its AbbVie (ABBV) stake by 0.16% in Q2 2026, selling an estimated $645 and leaving 1,927 shares worth $485K. The position accounts for 0.04% of the portfolio, ranked #65.
J.L. Bainbridge & Co first reported a position in ABBV in Q4 2021 and has held it in 17 quarters since. 2,220 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- J.L. Bainbridge & Co held 1,927 shares of AbbVie worth $485K as of Q2 2026.
- J.L. Bainbridge & Co sold 3 AbbVie shares in Q2 2026, an estimated $645.
- AbbVie made up 0.04% of J.L. Bainbridge & Co's portfolio in Q2 2026, its #65 holding.
- J.L. Bainbridge & Co first reported a position in AbbVie in Q4 2021 and has held it in 17 quarters since.
- 2,220 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on J.L. Bainbridge & Co's 13F filing for Q2 2026, filed 22 Jul 2026.